• J&J Could Axe 400 Scottish Jobs

    Up to 400 workers at a Johnson & Johnson surgical suture plant in Scotland could be out of work. The company said it will close the plant as part of its medical devices unit restructuring plans revealed last year. The suture facility accounts for less than 6% of the company's global capacity.Amanda Pedersen  Johnson & Johnson revealed plans last year to eliminate up to 6% of its medical device workforce, but the company stopped short of saying exactly what jobs would be on the...
  • How Graphene Could Enable Cheap Diagnostic Devices

    Researchers found a way to capture and analyze individual blood cells that could be used to make a variety of diagnostic devices for as little as $5 each.  Kristopher SturgisMild heating of graphene oxide sheets makes it possible to bond particular compounds to the sheets' surface. These compounds in turn select and bond specific molecules of interest, including DNA and proteins, or even whole cells. In this image, the treated graphene oxide on the right is nearly twice as efficient at...
  • Are Edwards and Bos Sci Headed for Cross-Licensing?

    Germany ruling suggests that the lengthy patent battle between Boston Scientific and Edwards Lifesciences may end in a cross-licensing agreement.Amanda Pedersen A cross-licensing agreement may inevitably be in Edwards Lifesciences' and Boston Scientific's future, but for now the two companies are still going toe-to-toe with one another over patent litigation related to transcatheter aortic valve replacement (TAVR) technology.Learn from industry leaders at BIOMEDevice Boston, May 3-4, 2017....
  • FDA Approves Stent for Troublesome Cardiac Artery Lesions

    The Tryton side-branch stent is compatible with stents manufactured to treat lesions in the main coronary artery, according to its North Carolina manufacturer.Nancy CrottiTryton Medical's side-branch stent is designed to treat, protect, and secure bifurcation lesions and integrates into any conventional drug-eluting main vessel stent.  FDA has approved a stent to treat plaque buildup in side branches of coronary arteries, nine years after the device received the CE mark in Europe....
  • FDA Warns Against TVAM Using Balloon Angioplasty Devices

    FDA issued a warning to patients and physicians against an experimental procedure called transvascular autonomic modulation (TVAM) using balloon angioplasty devices. The agency said TVAM puts patients at risk for several reasons.Amanda Pedersen Patients and doctors considering an experimental procedure called transvascular autonomic modulation (TVAM) for the treatment of autonomic dysfunction such as Parkinson's disease, MS, or fibromyalgia, among others, should really do their homework....
  • Smart Clothing Could Be Coming to Your Closet

    Forget accessories like smart watches. The next wave of wearable technology will be part of your wardrobe.Jamie HartfordKiourti's research has led to woven circuits that are as precise astraditional PCBs.Wearable form factors have been touted as a way to improve the stickiness of medical technologies, but even strapping on a fitness tracker or smart watch is an extra step that users may decide to skip. Thanks to new research, complying with therapy could soon be as easy as getting dressed in...
  • BIOMEDevice Boston 2017 Innovation Prize Official Rules

    NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN. A PURCHASE OR PAYMENT WILL NOT IMPROVE YOUR CHANCES OF WINNING. CONTEST IS VALID ONLY IN THE UNITED STATES (EXCLUDING PUERTO RICO) AND CANADA (EXCLUDING QUEBEC) – ENTRIES FROM PERSONS LIVING IN OTHER COUNTRIES WILL BE AUTOMATICALLY DISQUALIFIED. GENERAL CONDITIONS:The BIOMEDevice Boston Innovation Prize (the “Contest”) is sponsored by UBM LLC, 2901 28th St., Ste. 100, Santa Monica, CA 90405 (“UBM” or...
  • Ding Dong the Device Tax is (Almost) Dead

    GOP healthcare bill would permanently do away with the 2.3% medical device tax. AdvaMed and other industry trade groups have been strongly pushing for a permanent repeal of the device tax for months.Amanda Pedersen Republican lawmakers this week unveiled a plan that would dismantle key aspects of Obamacare and, so far, the bill has drawn wildly mixed reactions. In short, President Donald Trump loves it, conservatives and democrats hate it (albeit for very different reasons), and opinions...
  • Call for Entries: BIOMEDevice Boston 2017 Medtech Innovation Prize

    If you'll be showcasing an innovative medtech product or service at the upcoming BIOMEDevice Boston Expo May 3–4, enter our contest for a chance to be included in a special innovation tour for attendees. Entries are due March 31, 2017.UBM is looking to identify the most innovative exhibitors at BIOMEDevice Boston and give them the recognition they deserve. The BIOMEDevice Boston Innovation Prize is a contest acknowledging the most innovative products, services, and technologies developed...
  • Why Edwards-Bos Sci Battle is Far from Over

    A UK patent court issued a split decision in a case between Edwards Lifesciences and Boston Scientific, but the battle over the two companies’ transcatheter heart valve patents is far from over, and could ultimately settle in a cross-licensing agreement.Amanda Pedersen A UK patent court ruled that one of Boston Scientific’s patents related to outer seals for transcatheter heart valves, which was asserted against Edwards’ Sapien 3 valve, is invalid, but that a second patent is valid and...
  • Non-Phthalate Plasticizer Performs Comparably in Blood Bag Study

    Non-phthalate plasticizer suggested as a potential alternative to DEHP.By Daphne AllenA recent study demonstrates that a non-phthalate plasticizer performs comparably to a phthalate plasticizer when used in red blood cell storage bags. The non-phthalate plasticizer, Eastman 168 SG, was studied at the Blood Center of Wisconsin, reported Mark Brucks, market development manager, plasticizers, for Eastman.Consisting of DEHT (Bis (2-Ethylhexyl) Terephthalate), Eastman’s “sensitive grade” non-...
  • Could Exact Sciences Help Reverse This Troubling Cancer Trend?

    With colorectal cancer on the rise in young adults, the maker of the Cologuard noninvasive home test for the disease says it might be time to adjust the screening age.Nancy CrottiColorectal cancer is on the rise in young adults, according to a study by the American Cancer Society, which is recommending more screenings. That might represent an opportunity for a company that markets an alternative to the colonoscopy.Don't miss the BIOMEDevice Boston Conference and Expo, May 3–4, 2017.Exact...
  • How Abbott Is Gaining New ‘FlexAbility’ in Arrhythmia Market

    FDA approved Abbott’s FlexAbility sensor-enabled ablation catheter for atrial flutter. The device is among the many gems the company picked up in its $25 billion acquisition of St. Jude Medical. Amanda PedersenAbbott's FlexAbility ablation catheter is the second Sensor Enabled tool developed for the EnSite Precision cardiac mapping system. Abbott’s $25 billion acquisition of St. Jude Medical boosted the company’s status in the electrophysiology market. Among the many technology gems...
  • Emerging-Market Companies Set to Rise in Medtech

    You’ve heard about the rise of the emerging markets in the medical device industry, but this time, there’s a new twist on the trend.Marie ThibaultThe promise and rapid growth of healthcare in the emerging markets is old news by now. The potential of the medical device industry in emerging markets is often touted by large multinational companies that have meaningful presences in both developed and developing countries.That dynamic is starting to change, according to the findings of a new report...
  • Debris-Catching Device for TAVR Wins Over FDA Panel

    An FDA advisory panel recently recommended approval for Claret Medical's Sentinel Cerebral Protection System based on a lack of alternative options and a low safety risk, but questions remain about the clinical efficacy of the device. As a de novo application, the Sentinel did not require a formal panel vote.Amanda PedersenClaret Medical's Sentinel Cerebral Protection System got a green light from an FDA panel for use during TAVR procedures. The company now expects the device to be on the U.S....
  • Alere Has 99 Problems And Asia's Just One

    Alere Inc. said it will file its annual report late again this year as the company tries to sort out an accounting mess in Asia. Amanda Pedersen Alere Inc. can't seem to catch a break. The company filed for a 15-day extension for its annual report because it is trying to sort out inappropriate conduct at a subsidiary in South Korea that could shift the timing of some revenue transactions in 2013, 2014, 2015, and the first three quarters of 2016.Keep track of who's buying, selling, and...
  • How A New Blood Test Could Forecast Heart Attacks

    Data published in the Journal of the American College of Cardiology shows a new blood test detected a significant coronary obstruction 90% of the time, and also tipped doctors off to a patient's risk of a future heart attack.Amanda Pedersen A Massachusetts General Hospital cardiologist said Prevencio Inc.'s multi-protein blood test could represent a new standard of care for diagnosing heart disease and predicting heart attack risk.  A new blood test could change the way doctors...
  • Updated Blood Collection Device Draws 510(k) from FDA

    FDA cleared Velano Vascular's PIVO needle-free blood collection device, which attaches to a peripheral IV system. Nancy CrottiThe PIVO advances an inner tube via a slider mechanism through the peripheral IV catheter system. Velano Vascular has won 510(k) clearance for a next-generation version its blood-draw device aimed at reducing painful needle sticks.The PIVO, formerly called TIVA, is a  single-use, needle-free blood collection device that attaches to a peripheral IV system....
  • Medtronic Solitaire Passes Muster In The Real World

    Real-world experience with Medtronic's Solitaire stent retriever in patients suffering acute ischemic stroke shows the device can perform just as well in the real world as it did in four separate clinical trials.Amanda PedersenRegistry data presented at the International Stroke Conference showed Medtronic's Solitaire stent retriever performed as well in real-world clinical settings as it did in four separate randomized controlled trials. No matter how well a device performs in clinical...
  • How a Brain Implant Helped Three People Text

    Stanford engineers and neurosurgeons have developed a new experimental brain-controlled technology designed to help paralyzed patients channel thoughts into movement and speech.Kristopher SturgisStanford's Jaimie Henderson and Krishna Shenoy are part of a consortium working on an investigational brain-to-computer hookup. A project nearly 15 years in the making is beginning to come to fruition for a group of Stanford researchers who have been working tirelessly to create a new brain-...